Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)

NCT00991744 · clinicaltrials.gov ↗

PHASE3

Phase

SUSPENDED

Status

100

Enrollment

OTHER

Sponsor class

Stopped Sterility problems in DepoCyte production

Conditions

Acute Lymphoblastic Leukemia

Interventions

DRUG: Liposomal cytarabine
DRUG: Intrathecal triple

Sponsor

Nordic Society for Pediatric Hematology and Oncology

Collaborators

[object Object]